JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lubic, S. P.
Right arrow Articles by Giacomini, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lubic, S. P.
Right arrow Articles by Giacomini, J. C.

Increased 1,4-dihydropyridine binding sites in serum-stimulated cardiomyocyte hypertrophy

SP Lubic, KM Giacomini and JC Giacomini

Department of Pharmaceutical Chemistry, University of California, San Francisco.

Altered calcium channel number or function may be associated with myocardial hypertrophy. Treatment of cultured neonatal rat cardiomyocytes with norepinephrine or serum results in cellular hypertrophy without an increase in cell number. Cell culture is a convenient system for examining possible changes in channels and receptors associated with hypertrophy. The specific objective of this study was to measure the density of calcium channels in serum-free (as control), norepinephrine and serum-treated cardiomyocyte cultures. Measurements of high affinity [3H]nitrendipine binding and 45Ca++ uptake were made in K(+)-depolarized cardiomyocyte cultures. We report that there is an increased density of functional voltage-sensitive calcium channels in the serum-stimulated model of cardiomyocyte hypertrophy. This increased density of calcium channels in the serum- treated cells may represent a mechanism responsible for initiating and promoting cardiomyocyte hypertrophy.

Volume 270, Issue 2, pp. 697-701, 08/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
A. G. KLEBER and Y. RUDY
Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias
Physiol Rev, April 1, 2004; 84(2): 431 - 488.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
B. C. Heng, H. K. Haider, E. K.-W. Sim, T. Cao, and S. C. Ng
Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro
Cardiovasc Res, April 1, 2004; 62(1): 34 - 42.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Tamamori, H. Ito, M. Hiroe, Y. Terada, F. Marumo, and M.-A. Ikeda
Essential roles for G1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy
Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2036 - H2040.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Rohr, J. P. Kucera, and A. G. Kleber
Slow Conduction in Cardiac Tissue, I : Effects of a Reduction of Excitability Versus a Reduction of Electrical Coupling on Microconduction
Circ. Res., October 19, 1998; 83(8): 781 - 794.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics.